Literature DB >> 35240311

Reduced motion external defibrillation: Reduced subject motion with equivalent defibrillation efficiency validated in swine.

Ehud J Schmidt1, Hassan Elahi2, Eric S Meyer2, Ryan Baumgaertner2, Luca Neri2, Ronald D Berger3, Harikrishna Tandri2, David W Hunter2, Steven P Cohen3, Matt T Oberdier2, Henry R Halperin2.   

Abstract

BACKGROUND: External defibrillators are used for arrhythmia cardioversion and for defibrillating during cardiac arrest. During defibrillation, short-duration biphasic pulses cause intense motion due to rapid chest-wall muscle contraction. A reduced motion external defibrillator (RMD) was constructed by integrating a commercial defibrillator with a Tetanizing-waveform generator. A long-duration, low-amplitude, tetanizing waveform slowly stimulated the chest musculature before the biphasic pulse, reducing muscle contraction during the shock.
OBJECTIVE: The purpose of this study was to evaluate RMD defibrillation in swine for subject motion during defibrillation pulses and for defibrillation effectiveness. RMD defibrillation can reduce the duration of arrhythmia ablation therapy or simplify cardioversion procedures.
METHODS: The tetanizing unit delivered a triangular 1-kHz pulse of 0.25- to 2.0-second duration and 10- to 100-V peak amplitude, subsequently triggering the conventional defibrillator to output standard 1- to 200-J energy biphasic pulses at the next R wave. Forward limb motion was evaluated by measuring peak acceleration and limb work during RMD (tetanizing + biphasic) or biphasic pulse-only waveforms at 10-3-second sampling rate. Seven swine were arrested electrically and subsequently defibrillated. Biphasic pulse-only and RMD defibrillations were repeated 25-35 times per swine, varying tetanizing parameters and biphasic pulse energy. Defibrillation thresholds (DFTs) were established by measuring the minimum energy required to restore sinus rhythm with biphasic pulse-only or RMD defibrillations.
RESULTS: Two forward-limb acceleration peaks occurred during both the tetanizing waveform and biphasic pulse, indicating rapid and slower nociceptic (pain sensation) nerve fiber activation. Optimal RMD tetanizing parameters (25-35 V, 0.25- to 0.75-second duration), relative to biphasic pulse-only defibrillations, resulted in 74% ± 10% smaller peak accelerations and 85% ± 10% reduced limb work. DFT energies were identical when comparing RMD to biphasic pulse-only defibrillations.
CONCLUSION: Relative to conventional defibrillations, RMD defibrillations maintain rhythm restoration efficiency with drastically reduced subject motion.
Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardioversion; Defibrillation effectiveness; Defibrillation motion; Sudden cardiac arrest; Ventricular tachycardia

Mesh:

Year:  2022        PMID: 35240311      PMCID: PMC9250595          DOI: 10.1016/j.hrthm.2022.02.021

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.779


  32 in total

1.  Gaps in the ablation line as a potential cause of recovery from electrical isolation and their visualization using MRI.

Authors:  Ravi Ranjan; Ritsushi Kato; Menekhem M Zviman; Timm M Dickfeld; Ariel Roguin; Ronald D Berger; Gordon F Tomaselli; Henry R Halperin
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-04-14

2.  Initial clinical application of real-time MR imaging-guided ablation of cardiac arrhythmia in patients with atrial flutter.

Authors:  Peter Nordbeck; Harald H Quick; Wolfgang R Bauer; Georg Ertl; Mark E Ladd; Oliver Ritter
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

3.  Role of catheter ablation of ventricular tachycardia associated with structural heart disease.

Authors:  Roberto De Ponti
Journal:  World J Cardiol       Date:  2011-11-26

4.  Serum cardiac markers response to biphasic and monophasic electrical cardioversion for supraventricular tachyarrhythmia--a randomised study.

Authors:  Roman Skulec; Jan Belohlavek; Tomas Kovarnik; Jirí Kolar; Jana Gandalovicova; Vladimir Dytrych; Ales Linhart; Michael Aschermann
Journal:  Resuscitation       Date:  2006-08-09       Impact factor: 5.262

5.  A Magnetic Resonance Imaging-Conditional External Cardiac Defibrillator for Resuscitation Within the Magnetic Resonance Imaging Scanner Bore.

Authors:  Ehud J Schmidt; Ronald D Watkins; Menekhem M Zviman; Michael A Guttman; Wei Wang; Henry A Halperin
Journal:  Circ Cardiovasc Imaging       Date:  2016-10       Impact factor: 7.792

6.  A 1.5T MRI-conditional 12-lead electrocardiogram for MRI and intra-MR intervention.

Authors:  Zion Tsz Ho Tse; Charles L Dumoulin; Gari D Clifford; Jeff Schweitzer; Lei Qin; Julien Oster; Michael Jerosch-Herold; Raymond Y Kwong; Gregory Michaud; William G Stevenson; Ehud J Schmidt
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668

7.  Tetanizing prepulse: A novel strategy to mitigate implantable cardioverter-defibrillator shock-related pain.

Authors:  David W Hunter; Harikrishna Tandri; Henry Halperin; Leslie Tung; Ronald D Berger
Journal:  Heart Rhythm       Date:  2016-01-06       Impact factor: 6.343

Review 8.  Animal models of arrhythmia: classic electrophysiology to genetically modified large animals.

Authors:  Sebastian Clauss; Christina Bleyer; Dominik Schüttler; Philipp Tomsits; Simone Renner; Nikolai Klymiuk; Reza Wakili; Steffen Massberg; Eckhard Wolf; Stefan Kääb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

9.  Functional Near Infrared Spectroscopy: Enabling Routine Functional Brain Imaging.

Authors:  Meryem A Yücel; Juliette J Selb; Theodore J Huppert; Maria Angela Franceschini; David A Boas
Journal:  Curr Opin Biomed Eng       Date:  2017-10-06

10.  Capturing Pain in the Cortex during General Anesthesia: Near Infrared Spectroscopy Measures in Patients Undergoing Catheter Ablation of Arrhythmias.

Authors:  Barry D Kussman; Christopher M Aasted; Meryem A Yücel; Sarah C Steele; Mark E Alexander; David A Boas; David Borsook; Lino Becerra
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.